Experimental Cancer Therapy Saves Lives at CHOP, up for FDA Approval

Published on in CHOP News

Kashaun with familyThe experimental CAR T-cell therapy is up for FDA approval this year, and if approved, has the potential to help more leukemia patients like 7-year-old Kashaun.

Battling leukemia most of his young life, Kashaun was given the therapy pioneered here at CHOP when his cancer relapsed. He is now in remission, and his family is hopeful things have finally turned around for their young ‘super hero.’

Watch the story on NBC10.

Contributor Name

Amy Burkholder